Tags : Ready-To-Use Stable Liquid Glucagon

Xeris’ GVOKE (glucagon) Receives FDA’s Approval as The First Ready-To-Use

Shots:  The approval is based on three P-III studies (NCT02656069, NCT03091673, NCT03439072) assessing GVOKE vs conventional glucagon emergency kits in adults and children aged ≥2yrs. with T1D The studies demonstrated 100% treatment success in children & 99% in adults. Usability research assessing GVOKE PFS and GVOKE HypoPen resulted in ~100% success rate in administering a […]Read More